Conducted in partnership with FINEP and UNIFESP, the study investigates the use of crystabulation, a technique that uses freezing to destroy tumors; in 97% of cases, the effectiveness of the method was proven
O is ahead of an innovative study that promises to revolutionize the treatment of . The hospital is recruiting volunteers to test a minimally invasive procedure known as crystabulation. This technique consists of freezing the tumor at extreme temperatures of up to -170ºC, eliminating the need for traditional surgery. Although it is already used to treat other diseases, cryablation is now being evaluated specifically for breast cancer. The procedure is performed in an office, with local anesthesia, and lasts between 20 to 30 minutes, without hospitalization. However, it is applicable only to early stage tumors, up to 2 cm in diameter.
Since March this year, the study has been underway and should last up to five years, involving about 750 women. In the first phase, 60 participants underwent crystalling and later surgery. In 97% of cases, tumor was reduced, proving the effectiveness of the method. Research seeks to determine whether cryablation can be a viable alternative to conventional surgery, offering a less invasive and potential option to improve patients’ quality of life. Half of the study participants will undergo cryoablation, while the other half will undergo conventional surgeries, allowing a detailed comparison of the results.
Participation criteria are available on the HCor website, and interested parties are encouraged to apply. The research is especially relevant for older women who can benefit from a less aggressive procedure, and for younger women, positively impacting health and health budget, as it does not require prolonged hospitalization. According to Datasus data in 2023, São Paulo recorded more than 22,000 breast cancer diagnoses, followed by Minas Gerais and Paraná. Women diagnosed with the disease are encouraged to contact HCor for more information about research.
This study represents a significant step in the search for more effective and less invasive treatments for breast cancer. The possibility of replacing traditional surgery with a fast and without hospitalization procedure can transform the cancer treatment approach, offering hope and better quality of life for thousands of women. HCor continues to lead research that seeks medical innovations, reaffirming their commitment to patient health and well-being.
*With information from Danúbia Braga
*Report produced with the aid of AI
